Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.70B | 7.68B | 4.39B | 1.65B | 561.90M |
Gross Profit | 8.33B | 5.75B | 3.01B | 844.26M | 74.89M |
EBITDA | 2.96B | 1.39B | -688.24M | -1.83B | -1.71B |
Net Income | 2.06B | 571.89M | -1.24B | -2.21B | -1.93B |
Balance Sheet | |||||
Total Assets | 18.91B | 8.75B | 5.99B | 5.69B | 3.56B |
Cash, Cash Equivalents and Short-Term Investments | 9.17B | 4.83B | 2.61B | 3.29B | 1.86B |
Total Debt | 9.01B | 3.46B | 2.41B | 1.22B | 1.38B |
Total Liabilities | 13.52B | 5.67B | 3.55B | 2.02B | 1.90B |
Stockholders Equity | 5.32B | 3.08B | 2.43B | 3.68B | 1.66B |
Cash Flow | |||||
Free Cash Flow | 2.30B | 1.28B | -1.80B | -2.59B | -2.00B |
Operating Cash Flow | 3.94B | 2.43B | -830.41M | -1.52B | -1.34B |
Investing Cash Flow | -4.67B | -959.13M | -1.30B | -724.59M | -1.13B |
Financing Cash Flow | 5.14B | 885.08M | 1.08B | 4.03B | 3.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥25.70B | 6.14 | 2.43% | 9.31% | 100.81% | ||
79 Outperform | ¥40.32B | 21.51 | 1.14% | 22.71% | 84.60% | ||
77 Outperform | ¥20.48B | 45.14 | 5.31% | -3.81% | -41.33% | ||
73 Outperform | ¥38.19B | 21.21 | 1.53% | 16.09% | -5.66% | ||
68 Neutral | ¥28.11B | 62.34 | 3.09% | 2.92% | -74.66% | ||
65 Neutral | ¥24.13B | 11.24 | ― | 39.50% | 168.59% | ||
65 Neutral | $10.94B | 15.62 | 5.18% | 2.23% | 3.14% | -26.85% |
Inforich, Inc. announced corrections to its FY2025 Q1 Financial Results Briefing Material, initially disclosed on May 14, 2025. While the corrections do not affect the previously disclosed financial results summary, they have been updated on the company’s website. This announcement ensures transparency and accuracy in financial reporting, maintaining trust with stakeholders.
Inforich, Inc. reported a significant increase in its financial performance for the first quarter of the fiscal year ending December 31, 2025, with net sales rising by 43.8% and EBITDA growing by 119.2% compared to the previous year. Despite a decline in ordinary profit, the company has shown overall growth, indicating a positive trajectory for the fiscal year, which could strengthen its position in the market and benefit stakeholders.